Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Antiretroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro, , , , , , , , and . Antiviral Res, 96 (1): 51-58 (July 2012)Supercritical fluid extraction of heather (Calluna vulgaris) and evaluation of anti-hepatitis C virus activity of the extracts, , , , , , and . Virus Res, (2015)Virucidal activity of WHO-recommended formulations against enveloped viruses including Zika, Ebola and emerging Coronaviruses, , , , , , , , , and 9 other author(s). J Infect Dis, 215 (6): 902-906 (2017)Immune protection against reinfection with nonprimate hepacivirus, , , , , , , , , and 13 other author(s). Proc Natl Acad Sci U S A, 114 (12): E2430-E2439 (March 2017)Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir, , , , , , , , and . J Antimicrob Chemother, 72 (5): 1541-1543 (2017)Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011, , , , , , , , , and . Euro Surveill, 16 (33): pii: 19944 (August 2011)Characterization of determinants important for hepatitis C virus p7 function in morphogenesis using trans-complementation, , , , , , , and . J Virol, 83 (22): 11682-11693 (2009)Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes, , , , , , , , , and 2 other author(s). J Virol, 84 (11): 5751-5763 (2010)Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches, , , and . Expert Rev Gastroenterol Hepatol, 4 (1): 63-79 (2010)Two pathogen reduction technologies-methylene blue plus light and shortwave ultraviolet light-effectively inactivate hepatitis C virus in blood products, , , , , , and . Transfusion, 53 (5): 1010-1018 (August 2013)